Sarepta Therapeutics Inc Clinical Update: SRP-9003 for Limb-Girdle Muscular Dystrophy Type 2E Conference Call Transcript - Thomson StreetEvents

Sarepta Therapeutics Inc Clinical Update: SRP-9003 for Limb-Girdle Muscular Dystrophy Type 2E Conference Call Transcript

Sarepta Therapeutics Inc Clinical Update: SRP-9003 for Limb-Girdle Muscular Dystrophy Type 2E Conference Call Transcript - Thomson StreetEvents
Sarepta Therapeutics Inc Clinical Update: SRP-9003 for Limb-Girdle Muscular Dystrophy Type 2E Conference Call Transcript
Published Jun 08, 2020
19 pages (12946 words) — Published Jun 08, 2020
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of SRPT.OQ conference call or presentation 8-Jun-20 12:30pm GMT

  
Brief Excerpt:

...Operator Good morning, ladies and gentlemen, and welcome to the Sarepta Therapeutics' Clinical Update SRP-9003 for Limb-Girdle Muscular Dystrophy Type 2E. (Operator Instructions) As a reminder, today's program is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker today, Ian Estepan, Senior Vice President, Chief of Staff and Corporate Affairs. Please go ahead. Ian M. Estepan ...

  
Report Type:

Transcript

Source:
Company:
Sarepta Therapeutics Inc
Ticker
SRPT.OQ
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Sarepta Therapeutics Inc Q2 2020 Earnings Call Summary – 2020-08-05 – US$ 54.00 – Edited Brief of SRPT.OQ earnings conference call or presentation 5-Aug-20 8:30pm GMT

Sarepta Therapeutics Inc Q2 2020 Earnings Call Transcript – 2020-08-05 – US$ 54.00 – Edited Transcript of SRPT.OQ earnings conference call or presentation 5-Aug-20 8:30pm GMT

Sarepta Therapeutics Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) Transcript – 2020-06-24 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 24-Jun-20 4:30pm GMT

Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript – 2020-06-09 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 9-Jun-20 7:00pm GMT

Sarepta Therapeutics Inc Clinical Update: SRP-9003 for Limb-Girdle Muscular Dystrophy Type 2E Conference Call Summary – 2020-06-08 – US$ 54.00 – Edited Brief of SRPT.OQ conference call or presentation 8-Jun-20 12:30pm GMT

Sarepta Therapeutics Inc Annual Shareholders Meeting Transcript – 2020-06-04 – US$ 54.00 – Edited Transcript of SRPT.OQ shareholder or annual meeting 4-Jun-20 1:00pm GMT

Sarepta Therapeutics Inc at RBC Global Healthcare Conference (Virtual) Transcript – 2020-05-19 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 19-May-20 6:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Sarepta Therapeutics Inc Clinical Update: SRP-9003 for Limb-Girdle Muscular Dystrophy Type 2E Conference Call Transcript" Jun 08, 2020. Alacra Store. May 18, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Sarepta-Therapeutics-Inc-Clinical-Update-SRP-9003-for-Limb-Girdle-Muscular-Dystrophy-Type-2E-Conference-Call-T13220188>
  
APA:
Thomson StreetEvents. (2020). Sarepta Therapeutics Inc Clinical Update: SRP-9003 for Limb-Girdle Muscular Dystrophy Type 2E Conference Call Transcript Jun 08, 2020. New York, NY: Alacra Store. Retrieved May 18, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Sarepta-Therapeutics-Inc-Clinical-Update-SRP-9003-for-Limb-Girdle-Muscular-Dystrophy-Type-2E-Conference-Call-T13220188>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.